Rallybio Future Growth
Future criteria checks 2/6
Rallybio is forecast to grow earnings and revenue by 53.2% and 61.7% per annum respectively. EPS is expected to grow by 52.9% per annum. Return on equity is forecast to be -43.7% in 3 years.
Key information
53.2%
Earnings growth rate
52.9%
EPS growth rate
| Biotechs earnings growth | 30.0% |
| Revenue growth rate | 61.7% |
| Future return on equity | -43.7% |
| Analyst coverage | Low |
| Last updated | 12 Aug 2024 |
Recent future growth updates
Recent updates
We Think Rallybio (NASDAQ:RLYB) Needs To Drive Business Growth Carefully
Aug 28
Is Rallybio (NASDAQ:RLYB) In A Good Position To Deliver On Growth Plans?
Jan 04Is Rallybio (NASDAQ:RLYB) In A Good Position To Invest In Growth?
Sep 19Here's Why We're Not Too Worried About Rallybio's (NASDAQ:RLYB) Cash Burn Situation
May 15We Think Rallybio (NASDAQ:RLYB) Can Afford To Drive Business Growth
Jan 30Here's Why We're Not Too Worried About Rallybio's (NASDAQ:RLYB) Cash Burn Situation
Oct 31Here's Why We're Not Too Worried About Rallybio's (NASDAQ:RLYB) Cash Burn Situation
Jul 07Rallybio (NASDAQ:RLYB) Is In A Good Position To Deliver On Growth Plans
Mar 16Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | N/A | -62 | -12 | -40 | 2 |
| 12/31/2025 | 0 | -59 | -20 | -57 | 5 |
| 12/31/2024 | 0 | -65 | -18 | -26 | 5 |
| 6/30/2024 | 0 | -74 | -54 | -54 | N/A |
| 3/31/2024 | N/A | -76 | -57 | -57 | N/A |
| 12/31/2023 | N/A | -75 | -60 | -60 | N/A |
| 9/30/2023 | N/A | -71 | -64 | -64 | N/A |
| 6/30/2023 | N/A | -71 | -62 | -62 | N/A |
| 3/31/2023 | N/A | -69 | -62 | -62 | N/A |
| 12/31/2022 | N/A | -67 | -57 | -57 | N/A |
| 9/30/2022 | N/A | -63 | -52 | -52 | N/A |
| 6/30/2022 | N/A | -55 | -48 | -48 | N/A |
| 3/31/2022 | N/A | -48 | -48 | -47 | N/A |
| 12/31/2021 | N/A | -47 | -46 | -46 | N/A |
| 9/30/2021 | N/A | -45 | -43 | -43 | N/A |
| 6/30/2021 | N/A | -42 | -38 | -38 | N/A |
| 3/31/2021 | N/A | -36 | -29 | -28 | N/A |
| 12/31/2020 | N/A | -26 | -22 | -22 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: RLYB is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: RLYB is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: RLYB is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: RLYB's revenue (61.7% per year) is forecast to grow faster than the US market (8.8% per year).
High Growth Revenue: RLYB's revenue (61.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: RLYB is forecast to be unprofitable in 3 years.